Sutou Ichiro, Nakatani Toshihiko, Hashimoto Tatsuya, Saito Yoji
J Pain Palliat Care Pharmacother. 2015 Jun;29(2):161-5. doi: 10.3109/15360288.2015.1035832.
Opioids are not generally deemed to have an analgesic ceiling effect on cancer pain. However, there have been occasional reports of tolerance to opioid development induced by multiple doses of fentanyl. The authors report a case of suspected tolerance to the analgesic effect of opioid, in which an increasing dose of fentanyl failed to relieve the patient's cancer pain symptoms, but opioid switching to oxycodone injections enabled a dose reduction to below the equivalent dose conversion ratio. The patient was a 60-year-old man diagnosed with pancreatic body carcinoma with multiple metastases. The base dose consisted of 12 mg/day of transdermal fentanyl patches (equivalent to 3.6 mg/day, 150 μg/h fentanyl injection), and rescue therapy consisted of 10 mg immediate-release oxycodone powders. Despite the total daily dose of fentanyl reaching 5.6 mg (equivalent to 560 mg oral morphine), the analgesic effect was inadequate; thus, an urgent adjustment was necessary. Due to the moderate dose of fentanyl, the switch to oxycodone injection was done incrementally at a daily dose equivalent to 25% of the fentanyl injection. The total dose of oxycodone was replaced approximately 53.5% of the dose of fentanyl prior to opioid switching.
阿片类药物一般被认为对癌症疼痛没有镇痛封顶效应。然而,偶尔有报告称多次使用芬太尼会导致对阿片类药物产生耐受性。作者报告了一例疑似对阿片类药物镇痛效果产生耐受性的病例,其中芬太尼剂量增加未能缓解患者的癌症疼痛症状,但换用羟考酮注射液后剂量得以降至等效剂量转换比例以下。患者为一名60岁男性,诊断为胰体癌伴多发转移。基础剂量为每日12毫克透皮芬太尼贴剂(相当于每日3.6毫克,芬太尼注射液150微克/小时),解救治疗为10毫克即释羟考酮粉剂。尽管芬太尼每日总剂量达到5.6毫克(相当于口服吗啡560毫克),镇痛效果仍不充分;因此,需要紧急调整。由于芬太尼剂量适中,换用羟考酮注射液时以相当于芬太尼注射液25%的日剂量逐步进行。在换用阿片类药物之前,羟考酮的总剂量约为芬太尼剂量的53.5%。